Evaluation of usefullness of 1H MR spectroscopy for diagnosis of breast tumors.

Evaluation of usefullness of 1H MR spectroscopy for diagnosis of breast tumors. - Usefullness of 1H MR spectroscopy of breast tumors

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000002462

Enrollment

140

Registered

2009-09-09

Start date

2009-10-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

breast tumor

Interventions

We will perform 1H MR spectroscopy to the patients of the breast cancer and measure the density of choline compounds which related to the composition and metabolism of the phospholipid of cell membran

phylodes tumor, papilloma and fibrocystic disease.

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: 1) The patient who is doubted having breast tumor in palpation, sonography, or mammography. 2) The patient who is seen a solid breast tumor more than 1.5cm in minor axis by post-contrasted MRI 3) The patient who signed a written informed consent form.

Exclusion criteria

Exclusion criteria: 1) The patient who has any contraindication on MRI 2) The patient who cannot be taken contrast material of MRI. 3) The patient who has been taken biopsy of the breast tumor 4) The patient who ever has been taken surgery, chemotherapy, radiation or any other therapy for the breast tumor.

Design outcomes

Primary

Measure	Time frame
Measurement of density of choline compounds and tumor size before treatment	—

Countries

Japan

Contacts

Public ContactWaka Mizukoshi

International medical center, Saitama medical university Diagnostic Radiology

wsaito@saitama-med.ac.jp042-984-4520

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026